Have a feature idea you'd love to see implemented?
Let us know!
WVE Wave Life Sciences Ltd
Price (delayed)
$14.35
Market cap
$2.19B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.11
Enterprise value
$1.9B
Wave Life Sciences is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using
Highlights
The quick ratio has soared by 102% QoQ and by 24% YoY
Wave Life Sciences's debt has decreased by 19% YoY and by 6% QoQ
Wave Life Sciences's EPS has plunged by 95% from the previous quarter and by 31% YoY
The company's net income has shrunk by 94% QoQ and by 68% YoY
Key stats
What are the main financial stats of WVE
Market
Valuations
Earnings
Shares outstanding
152.52M
Market cap
$2.19B
Enterprise value
$1.9B
Price to earnings (P/E)
N/A
Price to book (P/B)
12.64
Price to sales (P/S)
35.48
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
35.53
Revenue
$53.61M
EBIT
-$142.52M
EBITDA
-$133.83M
Free cash flow
-$141.83M
Per share
Balance sheet
Liquidity
EPS
-$1.11
Free cash flow per share
-$1.07
Book value per share
$1.14
Revenue per share
$0.4
TBVPS
$2.7
Total assets
$358.5M
Total liabilities
$208.99M
Debt
$27.17M
Equity
$141.64M
Working capital
$153.79M
Debt to equity
0.19
Current ratio
1.9
Quick ratio
1.82
Net debt/EBITDA
2.12
Margins
Efficiency
Dividend
EBITDA margin
-249.6%
Gross margin
100%
Net margin
-265.8%
Operating margin
-283.6%
Return on assets
-52.9%
Return on equity
-280.6%
Return on invested capital
N/A
Return on capital employed
-75.9%
Return on sales
-265.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
WVE stock price
How has the Wave Life Sciences stock price performed over time
Intraday
0.63%
1 week
-4.33%
1 month
-5.03%
1 year
173.33%
YTD
184.16%
QTD
75%
Financial performance
How have Wave Life Sciences's revenue and profit performed over time
Revenue
$53.61M
Gross profit
$53.61M
Operating income
-$152.05M
Net income
-$142.52M
Gross margin
100%
Net margin
-265.8%
Wave Life Sciences's net margin has shrunk by 167% YoY
The operating margin has plunged by 161% YoY
The company's net income has shrunk by 94% QoQ and by 68% YoY
The operating income has plunged by 82% from the previous quarter and by 64% YoY
Growth
What is Wave Life Sciences's growth rate over time
Valuation
What is Wave Life Sciences stock price valuation
P/E
N/A
P/B
12.64
P/S
35.48
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
35.53
Wave Life Sciences's EPS has plunged by 95% from the previous quarter and by 31% YoY
Wave Life Sciences's revenue has shrunk by 51% QoQ and by 37% YoY
The P/S is 48% above the 5-year quarterly average of 24.0
Efficiency
How efficient is Wave Life Sciences business performance
Wave Life Sciences's ROS has plunged by 167% YoY
Wave Life Sciences's return on equity has surged by 80% QoQ
WVE's return on assets has dropped by 65% since the previous quarter and by 31% year-on-year
Dividends
What is WVE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for WVE.
Financial health
How did Wave Life Sciences financials performed over time
The total assets is 72% greater than the total liabilities
The quick ratio has soared by 102% QoQ and by 24% YoY
WVE's current ratio has soared by 92% since the previous quarter and by 19% year-on-year
Wave Life Sciences's debt is 81% lower than its equity
Wave Life Sciences's debt to equity has soared by 123% YoY and by 102% from the previous quarter
Wave Life Sciences's debt has decreased by 19% YoY and by 6% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.